AstraZeneca
AZN
#63
Rank
$271.29 B
Marketcap
$174.93
Share price
-1.66%
Change (1 day)
26.09%
Change (1 year)

AstraZeneca (AZN) - P/B ratio

P/B ratio as of June 2026 : 5.73

According to AstraZeneca's latest financial reports the company has a price-to-book ratio of 4.4887.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AstraZeneca - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-315.9118.61%
2024-12-314.98-6.72%
2023-12-315.34-5.93%
2022-12-315.6822.91%
2021-12-314.62-44.86%
2020-12-318.38-6.58%
2019-12-318.9733.36%
2018-12-316.7228.42%
2017-12-315.2426.54%
2016-12-314.14-11.43%
2015-12-314.672.46%
2014-12-314.5643.05%
2013-12-313.1930.18%
2012-12-312.45-5.1%
2011-12-312.58-7.22%
2010-12-312.78-15.01%
2009-12-313.27-11.54%
2008-12-313.70-11.59%
2007-12-314.18-21.39%
2006-12-315.32-6.66%
2005-12-315.7038.15%
2004-12-314.13-33.21%
2003-12-316.1815.01%
2002-12-315.37

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
6.77 18.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
7.21 25.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.59-72.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
2.92-48.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
31.4 448.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.20-79.07%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
1.56-72.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
6.12 6.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.49-4.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
4.40-23.14%๐Ÿ‡ฌ๐Ÿ‡ง UK